Blinatumomab candidate for standard-of-care in newly diagnosed B-ALL Presented ByProf. Mark Litzow, Mayo Clinic, MN, USA TrialPhase 3, ECOG-ACRIN-E1910 NCTN ConferenceASH 2022 20 February, 2023 11:07